EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study

뉴스 본문을 불러오고 있어요.

EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study | 웨이프 WAPE

EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study

기사 요약

관련 종목

댓글 —